All In Biotech

Drug Trial Radar · NCT01523587

LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy

LUX-Lung 8: A Randomized, Open-label Phase III Trial of Afatinib Versus Erlotinib in Patients With Advanced Squamous Cell Carcinoma of the Lung as Second-line Therapy Following First-line Platinum-based Chemotherapy

Last checked: Nov 19, 2026Latest source record: Feb 15, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 795 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

795

Actual

Start

Mar 5, 2012

Primary completion

Oct 21, 2013

Study completion Dec 27, 2017

Sponsor

Lead sponsor
Boehringer IngelheimBoehringer Ingelheim
Sponsor type
Industry
First posted
Feb 1, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This randomised, open-label phase III trial will be performed in patients with advanced squamous cell carcinoma of the lung requiring second-line treatment after receiving first-line platinum-based chemotherapy. The primary objective of this trial is to compare the efficacy of BIBW 2992 to erlotinib as second-line treatment in this group of patients.

Conditions

  • Carcinoma, Non-Small-Cell Lung

Interventions

  • afatinibDrug

    Afatinib taken once daily, continuously until disease progression or unacceptable toxicity.

  • erlotinibDrug

    erlotinib taken once daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Progression-free Survival, Based on Central Independent Review as Determined by Response Evaluation Criteria in Solid Tumours 1.1Time frame: First treatment administration up until cut off date of 02 March 2015 (up to 1058 days).

Locations

192 sites in 23 countries. Site status is shown where the registry gives one.

  • Ironwood Cancer and Research Centers

    Chandler, Arizona

  • University of California

    La Jolla, California

  • Sutter Medical Group

    Sacramento, California

  • Boca Raton Reginl Hospital-Lynn Cancer Institute

    Boca Raton, Florida

  • Memorial Healthcare System

    Hollywood, Florida

  • Cancer Care of North Florida, PA

    Lake City, Florida

  • Illinois Cancer Specialists

    Niles, Illinois

  • Orchard Healthcare Research Inc

    Skokie, Illinois

  • University of Louisville

    Louisville, Kentucky

  • West Jefferson General Hospital and Cancer Clinic

    Marrero, Louisiana

  • Lahey Clinic

    Burlington, Massachusetts

  • Commonwealth Hematology-Oncology, PC

    Lawrence, Massachusetts

  • Karmanos Cancer Institute

    Detroit, Michigan

  • Washington University School of Medicine

    St Louis, Missouri

  • Billings Clinic Cancer Center

    Billings, Montana

  • Queens Medical Associates

    Fresh Meadows, New York

  • SUNY Upstate Medical University

    Syracuse, New York

  • Montefiore Medical Center

    The Bronx, New York

  • Montefiore Medical Center

    The Bronx, New York

  • Cleveland Clinic

    Cleveland, Ohio

  • The Ohio State University Wexner Medical Center

    Columbus, Ohio

  • Mid Ohio Oncology/Hematology, Inc

    Columbus, Ohio

  • Kaiser Permanente Northwest

    Portland, Oregon

  • Oncology Hematology Associates of Norhtern Pennsylvania, PC

    DuBois, Pennsylvania

  • Kimmel Cancer Center

    Philadelphia, Pennsylvania

  • Temple University Cancer Center

    Philadelphia, Pennsylvania

  • Spartanburg Regional Medical Center

    Spartanburg, South Carolina

  • Cancer Center of Cookeville Regional Medical Center

    Cookeville, Tennessee

  • Paris Cancer Center (PCC), Texas Oncology

    Paris, Texas

  • Cancer Therapy and Research at UTHSCSA

    San Antonio, Texas

  • Fletcher Allen Health Care

    Burlington, Vermont

  • Blue Ridge Cancer Care

    Christiansburg, Virginia

  • Virginia Oncology Associates

    Norfolk, Virginia

  • Instituto Medico Especializado Alexander Fleming

    Ciudad Autonoma de Bs As, Argentina

  • Instituto Oncologico de Cordoba

    Córdoba, Argentina

  • Clínica Colombo S.A.

    Córdoba, Argentina

  • Centro Oncologico de Rosario

    Rosario, Argentina

  • Centro Oncologico CAIPO

    San Miguel de Tucumán, Argentina

  • Medical University of Innsbruck

    Innsbruck, Austria

  • LKH Leoben

    Leoben, Austria

Showing 40 of 192 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.